Ae Wealth Management LLC Ionis Pharmaceuticals Inc Transaction History

Ae Wealth Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 18, 2022	SELL	$29.88 - $37.04 $779,419 - $966,188	-26,085 Closed	0 $0
Q4 2021 Jan 20, 2022	BUY	$25.61 - $35.1 $668,036 - $915,583	26,085 New	26,085 $794,000
Q4 2019 Jan 15, 2020	SELL	$53.85 - $65.27 $329,508 - $399,387	-6,119 Closed	0 $0
Q3 2019 Nov 05, 2019	BUY	$59.06 - $72.15 $4,724 - $5,772	80 Added 1.32%	6,119 $367,000
Q2 2019 Jul 22, 2019	BUY	$62.09 - $86.14 $6,767 - $9,389	109 Added 1.84%	6,039 $388,000
Q1 2019 May 14, 2019	BUY	$52.92 - $81.17 $7,408 - $11,363	140 Added 2.42%	5,930 $481,000
Q4 2018 Feb 15, 2019	BUY	$43.37 - $59.54 $251,112 - $344,736	5,790 New	5,790 $313,000

403

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.35B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Ae Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Ae Wealth Management LLC with notifications on news.